Table of Contents

company-logo

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.

Nuvation Bio Dividend Announcement

• Nuvation Bio does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Nuvation Bio dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Nuvation Bio Dividend History

Nuvation Bio Dividend Yield

Nuvation Bio current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Nuvation Bio stock? Use our calculator to estimate your expected dividend yield:

Nuvation Bio Financial Ratios

P/E ratio-1.55
PEG ratio-0.12
P/B ratio1.64
ROE-108.68%
Payout ratio0.00%
Current ratio9.57
Quick ratio9.57
Cash Ratio0.51

Nuvation Bio Dividend FAQ

Does Nuvation Bio stock pay dividends?
Nuvation Bio does not currently pay dividends to its shareholders.
Has Nuvation Bio ever paid a dividend?
No, Nuvation Bio has no a history of paying dividends to its shareholders. Nuvation Bio is not known for its dividend payments.
Why doesn't Nuvation Bio pay dividends?
There are several potential reasons why Nuvation Bio would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Nuvation Bio ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Nuvation Bio has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Nuvation Bio a dividend aristocrat?
Nuvation Bio is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Nuvation Bio a dividend king?
Nuvation Bio is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Nuvation Bio a dividend stock?
No, Nuvation Bio is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Nuvation Bio stocks?
To buy Nuvation Bio you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Nuvation Bio stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.